Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Adhera Therapeutics, Inc. | v333013_ex5-1.htm |
| EX-3.11 - EXHIBIT 3.11 - Adhera Therapeutics, Inc. | v333013_ex3-11.htm |
| EX-4.19 - EXHIBIT 4.19 - Adhera Therapeutics, Inc. | v333013_ex4-19.htm |
| EX-23.1 - EXHIBIT 23.1 - Adhera Therapeutics, Inc. | v333013_ex23-1.htm |
| EX-10.96 - EXHIBIT 10.96 - Adhera Therapeutics, Inc. | v333013_ex10-96.htm |
| S-1/A - AMENDMENT TO FORM S-1 - Adhera Therapeutics, Inc. | v333013_s1a.htm |
Exhibit 21.1
List of Subsidiaries
| Name | State of Incorporation | Ownership | ||||||
| Cequent Pharmaceuticals, Inc. | Delaware | 100 | % | |||||
| MDRNA Research, Inc. | Delaware | 100 | % | |||||
| Atossa HealthCare, Inc. | Delaware | 100 | % | |||||